Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: FDA prioritizes inspections, McClellan on J&J board, Unilever told to pull Flora ProActiv ads, NAD reminds firms to support testimonials

This article was originally published in The Tan Sheet

Executive Summary

FDA on shutdown; McClellan on J&J board; Unilever told to pull U.K. Flora ProActiv ads; ERSP: dose must deliver nutritional benefits; NAD: firms must support testimonials; CPSC considers recall regs; Sabinsa’s Curcumin C3 is GRAS.


Related Content


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts